🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the optimal regimen for the use o...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2023-01-17
Trial ID
NCT04803006
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of TCD601 ...
Status
Completed
Location
University of California Davis Medical Center
Start Date
2023-12-28
Trial ID
NCT05669001
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability, pharm...
Status
Terminated
Location
Innsbruck Medical University
Start Date
2021-06-06
Trial ID
NCT06365437
Treatments Being Tested
The purpose of this study is to evaluate if TCD601 can induce allogeneic to...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2022-12-14
Trial ID
NCT04803058
Treatments Being Tested
The goal of this clinical trial is to learn if siplizumab can prevent rejec...
Status
Recruiting
Location
UC Davis Medical Center
Start Date
2026-06-29
Trial ID
NCT07508787
Treatments Being Tested
The purpose of this study is to find out whether siplizumab is safe and eff...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2023-09-28
Trial ID
NCT06078696
The purpose of this study is to investigate the safety, pharmacokinetics (P...
Status
Terminated
Location
Skåne University Hospital Malmö
Start Date
2024-04-16
Trial ID
NCT06453668
Treatments Being Tested
The goal of this study is to determine if treatment with TCD601 improves be...
Status
Terminated
Location
UZ Brussel
Start Date
2023-01-23
Trial ID
NCT06025110
This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study ...
Status
Terminated
Location
University of Colorado School of Medicine: Barbara Davis Center for Diabetes
Start Date
2023-05-18
Trial ID
NCT05574335
Treatments Being Tested
The purpose of this study is to evaluate if treatment with a siplizumab-bas...
Status
Active Not Recruiting
Location
Karolinska University Hospital
Start Date
2022-06-29
Trial ID
NCT06019507
Treatments Being Tested